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CYSTIC fibrosis (CF) is caused by mutations in the CF
gene, which encodes CF transmembrane conductance
regulator protein (CFTR),  a transmembrane protein
that acts as a cAMP-regulated chloride channel. The
disease  is  characterized  by  inflammation  but  the
relationship between inflammation, abnormal trans-
epithelial  ion  transport,  and  the clinical  manifesta-
tions  of  CF  are  uncertain.  The  present  study  was
undertaken to determine whether three nonsteroidal
anti-inflammatory  drugs  (NSAIDs)  (aspirin,  ibupro-
fen, and indomethacin) modulate CFTR gene expres-
sion  in  T-84  cells.  Treatment  with  NSAIDs  reduced
CFTR  transcripts,  and  decreased  cAMP-stimulated
anion fluxes, an index of CFTR function. However, the
two phenomena occurred at different concentrations
of both drugs. The results indicate that NSAIDs can
regulate both CFTR gene expression and the function
of CFTR-related chloride transport, and suggest that
NSAIDs act via multiple transduction pathways.
Keywords:  CFTR,  Gene  expression, T-84  Cells,  Aspirin,
Nonsteroidal anti-inflammatory drugs
Introduction
Inflammation  in  response  to  an  external  attack  or
internal  malfunction  triggers  the  synthesis  of  many
extra- and intracellular mediators that can modulate
the  activity  of  the  cell’s  membrane,  cytoplasm  and
nucleus. The  inhibitory  effects  of  aspirin  on  most
inflammatory responses have long been attributed to
its  ability  to  block  the  synthesis  of  prostaglandins.
These natural autaco¨ õds produced by cyclooxygenase
activation  provoke  inflammation.1 It  is  now  well
established  that  aspirin  and  the  other  nonsteroidal
anti-inflammatory  drugs  (NSAIDs)  also  modulate
membrane 2–6 and  nuclear7–9 responses  independ-
ently of the inhibition of cyclooxygenase. This raises
questions about the molecular reactions contributing
to the beneficial effects of NSAIDs on the symptoms
of cystic fibrosis (CF).10
CF transmembrane conductance regulator protein
(CFTR) is known to act as a cAMP-activated anionic
channel. Clinical manifestations of CF are correlated
with  mutations  in  the  CF  gene,  which  cause  the
protein it makes to function abnormally.11 However,
CF involves not only hydroelectrolytic abnormalities,
but also chronic inflammation and infection, and anti-
inflammatory  therapies  improve  the  clinical  condi-
tion of patients. The link between changes in anionic
transmembrane transport and inflammation is uncer-
tain, and some observations suggest that NSAIDs may
have  a  dual  effect  in  CF,  combining  inhibition  of
inflammation  with  the  modulation  of  anion  trans-
membrane transport.
Several  effects of rapid  modulations in ionic con-
ductances  by  NSAIDs  have  been  described.  For
example,  the  fenamates  (niflumic  and  flufenamic
acids)  block  the  nonselective  ion  channels  in  rat
exocrine pancreas,3 or activate the voltage-dependent
K  current  expressed  in  Xenopus  oocytes.6 Several
reports  indicate  that  NSAIDs  alter  chloride  con-
ductances  in  epithelial  cells.  Short  applications  of
NSAIDs  inhibit  Ca2+-  and  cAMP-regulated  chloride
secretion  of  cultured  tracheal  epithelial  cells.4 The
fenamates  also  modulate  chloride  conductance  in
bovine  retinal  pigment  epithelium,  but  in  a  more
complex way.5 Recently, it was reported that ibupro-
fen  blocks the CFTR-mediated chloride secretion  in
T-84 cells and in human and mouse tracheal epithe-
lia.2 Other data suggest that aspirin and other NSAIDs
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various transcription  factors which bind  to specific
nucleotidic  sequences  present  in  the  CFTR  pro-
moter.12 Aspirin  has  been  shown  to  inhibit  the
activation of transcription factors such as NFk B7 and
AP1
8, and to facilitate the binding capacity of the Heat
Shock  Factor,  HSF1.9 Indomethacin  has  also  been
shown to inhibit the activation of AP-1.8We suggested
that aspirin may control CFTR gene expression. This
would  not  be  the  first ‘nuclear  effect’  of  the  drug,
since  aspirin  had  already  been  shown  to  suppress
inflammation-induced expression of interleukin-1 (Il-
1), Il-6 and adhesion molecules in Hela cells7 and to
inhibit the synthesis of IL-1-induced PGH synthase.13
The  present  study  was  undertaken  to  determine
whether aspirin, ibuprofen, and indomethacin modify
CFTR gene function. We did this by measuring CFTR
transcripts and  cAMP-stimulated anion fluxes, these
being indices of CFTR function in T-84 cells.
Materials and methods
Cell culture and drug treatment
Human T-84 carcinoma cells were obtained from the
American  Type  Culture  Collection  (Rockville,  MD)
and  propagated  in  a  mixture  (1:1)  of  Dubelcco’s
modified  Eagle’s  medium  (DMEM)  and  Ham’s  F-12
medium containing 15mM Hepes and 10% fetal calf
serum (FCS). LLCPK cells stably transfected with wild
type  CFTR,  D F508-CFTR,  and  nontransfected  cells
were both cultured in DMEM medium.
The cells were seeded at a density of 23 104/cm2.
Stock  solutions  of  aspirin  (1mol/l),  indomethacin
(53 10–3mol/l),  and  ibuprofen  (10–2mol/l)  were
made up in ethanol. On the third day after passage,
the  cells  were  treated  with  aspirin  or  the  other
NSAIDs in FCS-enriched medium. RNA was analyzed
after  24h  of treatment  (except for  kinetic  studies).
Functional  studies  were  performed  on  T-84  cells
incubated  with  the  drugs  for  48h.  Control  cells
received the same volume of solvent  (<1%). All the
culture materials were obtained from Life Technolo-
gies  (Les  Ulis,  France);  the  drugs  were  from  Sigma
(France).
Analysis of cell viability
In  a  preliminary  series  of  experiments  we  verified
that, even at the highest concentrations used in this
study,  the  drugs  were  not  toxic.  Cells  maintained
under  control  conditions,  or  after  a  48-h  treatment
with aspirin (10–3mol/l), indomethacin (23 10–5mol/
l),  or  ibuprofen  (53 10–4mol/l)  were  washed  with
phosphate-buffered  saline  (PBS),  trypsinized,  sus-
pended in serum-free medium, and centrifuged. Cells
were washed twice more with PBS and suspended in
PBS. Parts of this suspension were used to test cell
viability  with  trypan  blue,  for  counting  cells  in  a
Malassez cell, and to measure protein concentration
according to Lowry et al.14
Cell  counting  and  trypan  blue  exclusion  test
showed that  when  10–3mol/l aspirin  was  added to
T-84 cells for a 48-h incubation, it neither killed them
nor  altered  their  proliferation  rate. The  same  treat-
ment also had no effect on the protein content of the
culture. The  same  results  were  observed  after  48-h
incubation  with  23 10–5mol/l  indomethacin  and
53 10–4mol/l ibuprofen (Table 1).
RNA extraction and analysis
Total  RNA  was  isolated  with  phenol/chloroform15
using the Trizol reagent (Life Technologies), according
to the manufacturer’s instructions. The RNA was then
fractionated on 0.9% agarose gels (15m g/well), trans-
ferred to nylon membranes (Promega Charbonni` eres,
France)  and  fixed  by  heating.  The  filters  were
hybridized  to  32P-labeled  cDNA  probes  (specific
activity  >109cpm/mg)  with the Quik  Hyb  protocol
provided  by  Stratagene  (Ozyme,  Les  Ulis,  France),
washed  under  stringent  conditions  (0.1  SSC,  0.1%
sodium  docdecyl  sulfate  at  52°C  for  20min)  and
autoradiographed at –80°C. The CFTR probe was the
1.5-kb EcoR1-EcoR1 fragment of human CFTR-cDNA
probe  labeled  by  random  priming. The  membranes
were rehybridized with a human b -actin cDNA probe
from Oncogene Science (France Biochem, Meudon,
France). The mRNAs were quantified by densitometric
scanning  of  the  autoradiograms  on  an  ImageMaster
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Table 1. Effects on NSAIDs on cell proliferation
Number of cells
(10
6 cells/well)
Living cells
(% of total)
Cell protein
(m g/well)
Control 1.55±0.11 90.9±2.4 220±25
Aspirin (53 10
–4mol/l) 1.85±0.25 91.3±2.7 234±21
Aspirin (10
–3mol/l) 1.40±0.06 91.4±3 223±30
Indomethacin (23 10
–5mol/l) 1.40±0.15 89.2±2.9 205±28
Ibuprofen (53 10
–4mol/l) 1.63±0.22 90.5±2.6 220±21
The number of cells per well, the percentage of living cells, and the protein content  were determined as
described in materials and methods on cultures maintained under control conditions or treated for 48h with
the various NSAIDs. Each value is the mean ±SE of three determinations performed in triplicate on three
different cultures.VSD  (Pharmacia-Biotech-Amersham,  Orsay,  France),
and CFTR mRNA amounts were normalized to those of
b -actin. All experiments were repeated at  least four
times.
6-Methoxy-N-ethylquinolinium fluorescence
assay
The 6-methoxy-N-ethylquinolinium (MEQ) was synthe-
sized  in  the  laboratory  according  to  the  method
described by Biwersi and Verkman.166-Methoxyquino-
line  (20mmol)  and  iondoethane  (40mmol)  were
allowed to react for 1 h with continuous stirring and
boiling.  After  cooling,  the  reaction  product  was
resuspended in ether, and filtered. The precipate was
washed twice in ether, then dissolved in ethanol/water
(20:1) by mild heating, avoiding the boiling point. The
undissolved residue was removed by filtration at 80°C
through glass wool, and the solution was allowed to
cristallyze  on  ice.  The  final  product  yielded  85%
6-methoxy-N-ethylquinolinium iodide: a bright yellow
solid with a fusion point of 184°C. The properties of
MEQ fluorescence were defined on a Stern–Volmer
plot  (F0/F=1+KCl[Cl],  in  which  F0 and  F are  the
fluorescence intensities in the absence and presence
of  chloride,  and  [Cl]  corresponds  to  the  chloride
concentration. The data were obtained by measuring
the fluorescence of KCl solutions (from 0 to 50mM)
supplemented  with  1 m M MEQ (excitation,  350nm;
emission,  440nm;  filters  were  from  Chroma  (Paris,
France)) using a SPEX Fluorolog spectrofluorometer
and  analyzed  with  DM3000  software  (Jobin  Yvon,
France). The  plot  was  linear,  with  a  Stern–Volmer
constant of 149 M–1 (Fig. 1). The plots obtained using
the same solutions supplemented with the different
NSAIDs  (aspirin,  indomethacin,  ibuprofen)  did  not
modify the Stern–Volmer constant (Fig. 1).
The  measurements  of  intracellular  MEQ  fluores-
cence change were carried out as previously descri-
bed.17 Briefly, T-84 cells subcultured on  glass slides
(control cells, and those treated for 48h with NSAIDs)
were washed from culture medium, then loaded with
MEQ and I– for 10min in hypotonic iodine solution
(1:2 dilution of the isotonic solution, pH 7.4, adjusted
with  NaOH,  containing  the  following  reagents:
138mmol/l  NaI,  2.4mmol/l  K2HPO4,  10mmol/l
Hepes,  1 mmol/l  CaCl2,  10mmol/l  glucose)  and
allowed to recover for 10min in isotonic I– solution
before being placed in  a perfusion chamber on the
stage  of  an  inverted  microscope  (Diaphot,  Nikon,
France), where they were continuously perfused at
37°C  with  isotonic  iodide  solution.  After  a  2 min
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FIG. 1. Stern–Volmer plot. The plot was established by measuring the fluorescence of a 1mmol/l MEQ solution, to which was
added increasing amounts of KCI from 0 up to 50mmol/l. The determinations were performed in water alone (. ), then with
10
–3mol/l aspirin (©), 10
–3mol/l ibuprofen (j ), or 53 10
–5mol/l indomethacin (d ).perfusion period, I– ions were replaced by NO3
– ions.
Because nitrate does not interact with MEQ, fluores-
cence  increases  as  cell  iodide  flows  from  the  cell
through  anion  pathways  in  the  plasma  membrane,
unmasking possible basal anion conductance. Chan-
ges in fluorescence under basal conditions, and with
the  cAMP  cocktail  (53 10–4mol/l  8-(4-chlorophe-
nylthio)-cAMP  (cpt-cAMP)  and  10–4mol/l  IBMX)  in
the  nitrate  perfusion  solution  were  recorded.  The
whole experiment was performed without NSAIDs in
the perfusion solutions. Fluorescence from the MEQ
was measured in  single cells with  a  digital  imaging
system and a CDD camera (Photonics Science, UK),
and the results were analyzed using Imstar software
(Paris,  France). The  initial  rate  of  increase  of  MEQ
fluorescence was measured in basal (D Fbasal/D t) and
stimulatory (D FcAMP/D t) conditions.17
To validate the MEQ technology as a  method for
investigating  CFTR  gene  function,  we  used  LLCPK
cells  stably  transfected  with  the  wild-type  or  the
D F508-CFTR-mutated human cDNA CFTR gene.18The
cells  were  then  assayed  with  the  MEQ  technology
already described. Figure 2 shows that the function of
CFTR  gene  induces  an  increase  in  the  rate  of
fluorescence after the addition to the perfusate of the
cAMP  cocktail  in  the  CFTR-LLCPK  cells.  No  cAMP-
dependent  fluorescence  changes  were  detected  in
LLCPK  nontransfected  cells  or  D F508-CFTR-LLCPK
cells. Thus, the MEQ assay can be taken as an index of
CFTR activity.
Statistical analysis
Statistical  analysis  was  by  unpaired  Student’s  t-test,
and, where appropriate, by analysis of variance, with
P < 0.05 considered statistically significant.
Results
Variation in CFTR mRNA levels
The modulation of CFTR gene expression by NSAIDs
was investigated by Northern blot analysis, performed
on proliferating cells.
The relative amount of CFTR gene products (nor-
malized to b -actin products) was first determined in
cells  treated  for  24h  with  aspirin,  ibuprofen  and
indomethacin.  Figure  3A  and  B  shows  that,  under
our experimental conditions, aspirin (53 10–4mol/l),
ibuprofen  (53 10–4mol/l),  and  indomethacin
(23 10–5mol/l) reduced the amount of CFTR mRNA
in T-84 cells.
After  treating  the  cells  for  24h  with  aspirin,  the
amount  of  CFTR  mRNA  was  unaltered  by  low
concentrations of the drug, and was decreased by the
concentrations larger than 10–4mol/l (Fig. 4A). A half-
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FIG. 2. Validation of the MEQ technology. The fluorescence of intracellular MEQ was registered in untransfected LLCPK cells
(h ) and in LLCPK cells expressing either the wild type CFTR (s ) or the D F508-CFTR (d ), under sequential anionic substitutions
of the superfusing medium and addition of permeant cpt-cAMP, as indicated in the inset and described in materials and
methods.maximal  inhibition  was  observed  with  aspirin  con-
centrations  close  to  10–3mol/l.  b -actin  transcripts
were  unchanged.  Figure  4B  shows  the  action  of
aspirin  in  relation  to  time,  with  the  concentration
23 10–3mol/l (corresponding to an 80% inhibition of
CFTR transcripts after 24h of treatment) chosen for
these  experiments.  After  6 h  of  treatment,  a  50%
inhibition was observed, and the effect was greatest
after 9h. Together, the data show that the CFTR down-
regulation  is  concentration  and  time  dependent.
Indomethacin (10–5 and 23 10–5mol/l) and ibuprofen
(10–4 and 53 10–4mol/l) also significantly decreased
CFTR  mRNA  levels  in  a  concentration-dependent
manner (Fig. 5). The cell content in b -actin mRNA was
not  altered  by  indomethacin  or  ibuprofen  at  any
concentration (result not shown).
A  relationship  between  the  anti-inflammatory
effects of aspirin, indomethacin, and ibuprofen, and
their ability to decrease CFTR mRNA might proceed
from their capacity to inhibit cyclooxygenase activity.
To test this hypothesis, exogenous prostaglandin  E2
(PGE2) was added to the cells at the same time as the
NSAIDs. As  shown  in  Fig.  6,  10–6mol/l  exogenous
PGE2 by  itself  decreased  cell  CFTR mRNA  content,
and  when  added  with  aspirin,  indomethacin,  and
ibuprofen,  it  did  not  prevent  their  down-regulating
effect. Therefore, the decrease in CFTR gene expres-
sion induced by the NSAIDs cannot be linked to the
inhibition of cyclooxygenase activity.
Functional studies: MEQ assay
To  determine  whether  the  NSAIDs  modulated  the
function  of  CFTR  protein,  we  performed  a  MEQ
assay,  in  the  absence  of  the  drugs,  on  T-84  cells
treated  for  24  and  48h  with  53 10–4mol/l  aspirin,
53 10–4mol/l  ibuprofen,  and  23 10–5mol/l  indom-
ethacin  (Table  2). The  results  were  compared  with
Regulation of CFTR gene expression by aspirin
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FIG. 3. Effects of aspirin, indomethacin, and ibuprofen on CFTR mRNA content in T-84 cells. (A) Representative Northern blot
performed with 15m g total RNA extracted from cells treated for 24h with the indicated concentrations (mol/l) of NSAIDs. (B)
Amounts of CFTR transcripts normalized to those of b -actin mRNA. Each value is the mean±SE of four experiments. * P<0.05;
** P < 0.01.those  obtained  with  untreated  cells  studied  on  the
same  day.  In  the  control  (untreated)  T-84  cells,
addition  of  the  permeant  cAMP  (cpt-cAMP,
53 10–4mol/l) to the nitrate-containing solution aug-
mented  the  rate  of  increase  of  MEQ  fluorescence,
quantified  by  the  ratio  D FcAMP
ctl/D Fbasal
ctl (mean
values, 7.8; n=28; Table 2). This points to activation
of the cAMP-regulated anion pathway(s) (Fig. 7). The
24-h treatment of T-84 cells with either drug did not
change the cpt-cAMP-induced increase in the rate of
MEQ fluorescence observed in NO3
–-containing solu-
tions (data not shown). On the other hand, the cpt-
cAMP-induced  increase  in  the  rate  of  MEQ  fluores-
cence  observed  in  NO3
–-containing  solutions  was
altered in cells treated during 48h with the NSAIDs.
It  was  abolished  in  the  cells  treated  with  aspirin
(10–3mol/l),  (Fig.  7A  and  Table  2,  row  ‘aspirin’,
comparing  columns  2  and  5,  or  columns  3  and  6)
and  decreased  in  the  cells  treated  for  48h  with
53 10–4mol/l  ibuprofen  (Fig.  7B  and Table  2,  row
‘ibuprofen’, comparing columns 2 and 5, or 3 and 6)
or 23 10–5mol/l indomethacin (Table 2, row ‘indom-
ethacin’,  comparing column 2  and  5, or 3  and  6).
Using the MEQ methodology, we have thus shown
a decrease in cAMP-induced anionic flux provoked by
the treatment of the cells with aspirin, indomethacin,
and  ibuprofen,  and  also  demonstrated  a  particular
action  of  ibuprofen  and  aspirin  on  T-84  cell  basal
anion  conductance.  Under  our  experimental  proto-
col, this basal anion conductance (evidenced by the
light emission provoked by replacing I– by NO3
– in the
superfusing solution) was small (as Fig. 7A and Table
D. Tondelier et al.
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FIG. 4. Northern blot analysis of concentration and time dependence of CFTR mRNA decay induced by aspirin in T-84 cells. The
Northern blots were performed using 15m g total mRNA. The cell content in CFTR mRNA are normalized to the content in
b -actin mRNA, and the results are expressed as a percentage of the ratio determined on control cells. (A) Concentration
dependence. Cells were treated for 24h with 0, 10
–4, 53 10
–4, 10
–3, and 23 10
–3mol/l aspirin. Each value is the mean ±SE of six
determinations. * P<0.05; ** P<0.01. (B) Time dependence. Cells were treated with 23 10
–3mol/l aspirin for 0, 1, 3, 6, 9, 12 and
24h. Each value is the mean ±SE of five determinations. ** P<0.01.
FIG. 5. Concentration dependence of the decay of CFTR transcripts induced by ibuprofen and indomethacin. Northern blots
were performed using 15m g total RNA extracted from cells treated for 24h with various concentrations of ibuprofen and
indomethacin. The cell content in CFTR mRNA is normalized to the content in b -actin mRNA, and the results are expressed as
a percentage of the ratio determined on control cells. * P<0.05; ** P<0.01 (n = 5).Regulation of CFTR gene expression by aspirin
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FIG. 6. Absence of  the  effect  of  exogenous PGE2.  Typical
Northern  blot performed  using 15m g  total  RNA  extracted
from  cells  treated  for  24h  with  aspirin,  ibuprofen,  and
indomethacin in the absence and the presence of exogenous
PGE2 (10
–6mol/l)
FIG. 7. The fluorescence of intracellular MEQ was measured with respect to time under control conditions and after 48h of
treatment with either 53 10
–4mol/l aspirin (A) or 53 10
–4mol/l ibuprofen (B). The sequence of buffer substitutions is indicated
in the inset.
(A)
(B)
2, row ‘aspirin’, column 1). Treatment of the cells with
the three tested NSAIDs modulated this parameter in
various ways (column 4, Table 2). Aspirin decreased it
twofold (columns 4 and 7, Table 2), indomethacin was
without effect (Table 2, row ‘indomethacin’, columns
4 and 7), and ibuprofen increased it twofold (Figure
7B and Table 2, row ‘ibuprofen’, columns 4 and 7).
Discussion
The present study shows that aspirin, indomethacin,
and  ibuprofen, three nonsteroidal  anti-inflammatory
drugs widely used in clinical medicine, decrease both
the amount of CFTR transcripts and the function of
CFTR protein in human T-84 cells.
The decrease in CFTR mRNA does not appear to be
toxic,  because  there  was  no  sign  of  death  in  cells
incubated for 48h with the highest concentrations of
the drugs used, and  because the amount of b -actin
mRNA did not change in parallel with that of CFTR
mRNA. The high concentrations of aspirin and other
drugs required to down-regulate CFTR gene expres-
sion raise two issues: first, the possible existence of
such  an  effect  during  anti-inflammatory  treatment;second, the relationship between the modulation of
CFTR gene expression and cyclooxygenase inhibition.
Plasma  concentrations  of  aspirin  as  high  as  those
required to modulate  CFTR gene expression  in  our
experimental  model  (over  10–4mol/l)  have  been
reported  when  the drug  is used  for  sustained  peri-
ods,19 so  our  results  may  have  clinical  relevance.
However, the concentrations of aspirin, indomethacin,
or ibuprofen required to reduce CFTR gene expression
in  T-84  cells  are  not  consistent  with  the  direct
implication  of  cyclooxygenase  (COX)  inhibition,
whether of the constitutive COX-1 or the inducible
COX-2.  Aspirin,  indomethacin,  and  ibuprofen  are
better inhibitors of COX-1 than of COX-2, and  thus
have a higher ID50 for COX-2 than for COX-1; but even
their reported ID50 for COX-220is at least 10-fold lower
than their active concentrations in the present study.
Furthermore, the failure of exogenous PGE2 to prevent
the  decrease  in  CFTR  gene  expression  caused  by
aspirin, indomethacin, and ibuprofen suggests that this
effect of the NSAIDs does not involve the inhibition of
prostaglandin  synthesis. The  NSAID  concentrations
used in the present study are comparable with those
used in recent studies of the effects of these drugs on
the nucleus. This is the case for indomethacin binding
to the  peroxysome proliferator-activated  receptor g
(PPARg ).21 High  concentrations  of  aspirin  are  also
required to modulate the effect of the transcription
factors such as NFk B, AP1, or HSF,7–9 which possess
specific binding sites in the CFTR promoter,12 and may
thus be involved in the NSAID-induced down-regula-
tion of CFTR gene expression. Further studies will be
required  to  demonstrate  the  existence  of  any  such
regulation of CFTR gene expression by aspirin and its
derivatives. Since the transcription factors affected by
aspirin are activated during inflammation, this putative
mechanism of negative modulation of CFTR expres-
sion would also result from an anti-inflammatory effect
of the NSAIDs.
The cAMP-stimulated  anionic efflux measured  by
the MEQ assay was also decreased by treating the T-84
cells with aspirin, indomethacin, or ibuprofen. Since
the experiments were performed without NSAIDs, this
effect  of  the  NSAIDs  differed  from  the  immediate
inhibition  of  the ionic  transport  described in  other
studies.2–6 The  present  data  demonstrate  that  the
NSAIDs also exert a delayed action on anionic fluxes.
The results showing differences in the concentration
dependence of cAMP-regulated anion fluxes and in the
modulation of CFTR mRNA production argue against a
direct causal relationship between the two effects of
NSAIDs. Two points may be made. First, the relative
inhibition of cAMP-triggered anion efflux is larger than
the  relative  decrease  in  CFTR  transcripts. This  was
particularly obvious in cells treated with 53 10–4mol/l
aspirin, which no longer responded to cAMP in term of
anionic efflux, despite a decrease of only about 30% in
their  CFTR mRNA  content.  Second, very few CFTR
channels seem to be necessary for this function.11 In
normal  tissues,  this  small  number  of  channels  is
correlated with a quantity of CFTR gene products too
small to be visualized by Northern blotting. Our results
therefore suggest that aspirin, ibuprofen and indom-
ethacin have long-acting effects on CFTR function, in
addition to their action on CFTR gene expression. The
NSAIDs may alter the cytoplasmic processing and/or
turn-over of the CFTR protein, or change its potential
for  activation.  These  processes  are  modulated  by
variations in temperature and by various compounds
(butyrate, glycerol) (a review 22), and the demonstra-
tion of their sensitivity to NSAIDs would be particularly
interesting in the cystic fibrosis context. Immunoblots
of CFTR protein in control cells and cells exposed for
48h  to  0.5mmol/l  aspirin,  incubated  with  radio-
labeled methionine then incubated for 2–30h showed
no  clear  alteration  in  the  time-course  of  the  CFTR
protein  glycosylation  or  degradation,  but  only  a
general  decrease in the intensities of immature and
D. Tondelier et al.
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Table 2. Analysis of MEQ fluorescence in T84 cells
D Fbasal
ctl/D t,
untreated cells
D FcAMP
ctl/D t,
untreated cells
D FcAMP
ctl/D Fbasal
ctl,
untreated cells
D Fbasal
test/D t,
treated cells
D FcAMP
test/D t,
treated cells
D FcAMP
test/D Fbasal
test,
treated cells
D Fbasal
test/D Fbasal
ctl
(column 1) (column 2) (column 3) (column 4) (column 5) (column 6) (column 7)
Aspirin
(0.5mmol/l)
0.26±0.04
(10)
2.02±0.38
(10)
7.8 0.10±0.06a
(10)
0.19±0.03
(10)
1.9 0.38
Ibuprofen
(0.5mmol/l)
0.24±0.04
(6)
2.15±0.14
(6)
8.9 0.58±0.05b
(6)
1.40±0.15
(6)
2.4 2.41
Indomethacin
(2 m mol/l)
0.29±0.02
(8)
1.80±0.18
(8)
6.9 0.25±0.04c
(8)
0.58±0.07
(8)
2.3 0.86
Untreated cells: D Fbasal
ctl/D t, changes in MEQ fluorescence observed in unstimulated cells; D FcAMP
ctl/D Fbasal
ctl, changes in MEQ fluorescence
observed in cells exposed to cAMP cocktail; D FcAMP
ctl/D Fbasal
ctl, values obtained by dividing values from column 2 by those from column 1.
NSAIDS-treated cells for 48h: D Fbasal
test/D t, changes observed in unstimulated cells; D FcAMP
test/D t, changes in MEQ fluorescence observed in cells
exposed to cAMP cocktail; D FcAMP
test/D Fbasal
test, values obtained by dividing values from column 5 by those from column 4; D Fbasal
test/ D Fbasal
ctl,
values obtained  by  dividing  the values from  column  4  by  those  from  column  1. Numbers in  parentheses corresponds to  the  number of
independent experiments.
aStatistically different from values presented in the line aspirin, column 1, at P<0.05.
bStatistically different from values presented in the line ibuprofen, column 1, at P<0.01.
cNot significant from the values presented in the line indomethacin, column 1.fully glycosylated CFTR protein bands. The latter were
very faint in NSAID-treated cells (result not shown).
These results suggest that there is an aspirin-induced
decrease in the synthesis of native CFTR protein, but
further studies are required to specify the action of
aspirin on CFTR protein processing.
A decrease in endogenous CFTR activators caused
by  NSAIDs  cannot  be due  to altered  production  of
intracellular  endogenous  cAMP  because  the  MEQ
assay was performed with exogenous permeant cpt-
cAMP. Other cytoplasmic factors that  control CFTR
function  may  also  be  affected  by  the  NSAIDs.  For
example, indomethacin acts as an irreversible inhib-
itor of cAMP-dependent protein kinase in rabbit ileal
mucosa,23 and  inhibits  phospholipase A2  in  rabbit
polymorphonuclear leukocytes.24 Such effects could
alter  CFTR  function  directly  or  indirectly,  but  are
unlikely  since  there  were  no  changes  in  cAMP-
induced MEQ fluorescence in cells incubated for only
24h with NSAIDs.
However,  the  use  of  the  MEQ  methodology  did
reveal that  ibuprofen  also appears to  induce a  new
cAMP-independent anion conductance, which can be
activated in T-84 cells without further stimulation. This
effect may correspond to an increased number and/or
function  of  another  chloride  channel,  and  thus
contribute  to  the  improved  clinical  status  of  CF
patients treated with ibuprofen.
The present results emphasize the possible diver-
sity  of the NSAID effects, since these drugs, which
inhibit  CFTR  activity  accutely,2–6 also  appear  to
produce a delayed decrease in CFTR gene expression
and  cAMP-stimulated  anionic  efflux.  The  delayed
decrease in CFTR protein function does not appear to
result from a decrease in gene expression alone. The
NSAIDs  thus  appear  to  have  a  broad  spectrum  of
action on CFTR, which may reflect a general modifica-
tion of cell metabolism. This suggest that CFTR acts as
a  ‘housekeeping  gene’  that  can  adapt  to  various
physiological or pharmacological disturbances.25
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